BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

NCT05250895 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

BCLC Stage a Hepatocellular Carcinoma
BCLC Stage B Hepatocellular Carcinoma
BCLC Stage C Hepatocellular Carcinoma
Hepatocellular Carcinoma

Interventions

OTHER: 18F-Fluoromisonidazole
PROCEDURE: Biopsy
PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

Emory University

Collaborators

[object Object]